Enhanced Anti-Cancer Effect of Folate-Conjugated Olaparib Nanoparticles Combined with Radiotherapy in Cervical Carcinoma
Dong Li,1,* Chuanfei Hu,1,* Juan Yang,1 Yin Liao,1 Yue Chen,2,3 Shao Zhi Fu,1 Jing Bo Wu1,3 1Department of Oncology, The Affiliated Hospital of Southwest Medical University, Luzhou 646000, People’s Republic of China; 2Department of Nuclear Medicine, The Affiliated Hospital of Southwest Med...
Main Authors: | Li D, Hu C, Yang J, Liao Y, Chen Y, Fu SZ, Wu JB |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2020-12-01
|
Series: | International Journal of Nanomedicine |
Subjects: | |
Online Access: | https://www.dovepress.com/enhanced-anti-cancer-effect-of-folate-conjugated-olaparib-nanoparticle-peer-reviewed-article-IJN |
Similar Items
-
Olaparib nanoparticles potentiated radiosensitization effects on lung cancer
by: Wu M, et al.
Published: (2018-12-01) -
Profile of olaparib in the treatment of advanced ovarian cancer
by: Chase DM, et al.
Published: (2016-04-01) -
Complete pathological response to olaparib and bevacizumab in advanced cervical cancer following chemoradiation in a BRCA1 mutation carrier: a case report
by: Rosa Montero-Macias, et al.
Published: (2021-04-01) -
OLAPARIB: A promising PARP Inhibitor for the treatment of ovarian cancer
by: Soupos Nikolaos, et al.
Published: (2015-09-01) -
The use of PARP inhibitor - olaparib for the treatment of ovarian cancer in clinical practice
by: S V Khokhlova
Published: (2016-12-01)